Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid versus microfragmented adipose tissue for knee osteoarthritis
RBR-9bsf32rPhase 3Recruiting
- Sponsor
- Instituto de Ortopedia e Traumatologia
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone hexacetonide and autologous micro-fragmented adipose tissue in knee osteoarthritis (OA) (2 arms), sponsored by Instituto de Ortopedia e Traumatologia. Started Nov 2021; status: recruiting.
02
Drugs
triamcinolone hexacetonideautologous micro-fragmented adipose tissue
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-9bsf32r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9bsf32r.